Carregant...
Recent advances in managing axial spondyloarthritis
Axial spondyloarthritis (axSpA) is a chronic inflammatory rheumatic disease that predominantly affects the axial skeleton. The advent of biologic drugs has transformed the management of patients with axSpA. However, non-steroidal anti-inflammatory drugs remain the first-line drug treatment for axSpA...
Guardat en:
| Publicat a: | F1000Res |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
F1000 Research Limited
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7359748/ https://ncbi.nlm.nih.gov/pubmed/32704350 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.22577.1 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|